The cost‐effectiveness of multi‐purpose HIV and pregnancy prevention technologies in South Africa-Reference-Cited by-同舟云学术

The cost‐effectiveness of multi‐purpose HIV and pregnancy prevention technologies in South Africa

Published:2018-03 Issue:3 Volume:21 Page:
ISSN:1758-2652
Container-title:Journal of the International AIDS Society
language:en
Short-container-title:J Intern AIDS Soc

Author:

Quaife Matthew¹²^ORCID,Terris‐Prestholt Fern¹,Eakle Robyn¹²^ORCID,Cabrera Escobar Maria A.²,Kilbourne‐Brook Maggie³,Mvundura Mercy³,Meyer‐Rath Gesine⁴⁵,Delany‐Moretlwe Sinead²,Vickerman Peter⁶^ORCID

Affiliation:

1. Department of Global Health and Development London School of Hygiene and Tropical Medicine London UK

2. Wits RHI University of the Witwatersrand Johannesburg South Africa

3. PATH Seattle WA USA

4. Center for Global Health and Development Boston University Boston MA USA

5. Health Economics and Epidemiology Research Office Department of Internal Medicine Faculty of Health Sciences University of the Witwatersrand Johannesburg South Africa

6. School of Social and Community Medicine University of Bristol Bristol UK

Funder

Bill and Melinda Gates Foundation

Economic and Social Research Council

United States Agency for International Development

Department for International Development

Publisher

Wiley

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jia2.25064

Reference64 articles.

1. Effectiveness and safety of oral HIV preexposure prophylaxis for all populations

2. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial

3. On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection

4. NelA KapigaS BekkerL‐G DevlinB BorremansM RosenbergZ et al.Safety and Efficacy of Dapivirine Vaginal Ring for HIV‐1 Prevention in African Women. CROI 2016; Seattle USA2016.

5. BaetenJM Palanee‐PhillipsT BrownER SchwartzK Soto‐TorresLE NelA et al.A Phase III Trial of the Dapivirine Vaginal Ring for HIV‐1 Prevention in Women. Conference on Retroviruses and Opportunistic Infections Boston MA2016.

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preferences for Long-Acting PrEP Products Among Women and Girls: A Quantitative Survey and Discrete Choice Experiment in Eswatini, Kenya, and South Africa;AIDS and Behavior;2023-11-16

2. Preferences, educational messaging, and demand creation channels for multipurpose-prevention technologies (MPTs) among women in South Africa;BMC Public Health;2023-10-25

3. Program impact and potential pitfalls of multi-purpose technologies (MPTs) for HIV prevention and contraception;Frontiers in Reproductive Health;2023-09-01

4. Implementation and resource needs for long‐acting PrEP in low‐ and middle‐income countries: a scoping review;Journal of the International AIDS Society;2023-07

5. Commentary: Multipurpose prevention technologies—What about sexually transmitted infections?;Frontiers in Reproductive Health;2023-06-02